Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-067746
Filing Date
2025-07-14
Accepted
2025-07-14 16:05:21
Documents
1
Period of Report
2025-07-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2520709-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2520709-1_4seq1.xml 4 3387
  Complete submission text file 0001104659-25-067746.txt   5012
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 3300 LOWELL STREET NW WASHINGTON DC 20008
Business Address
Birx Deborah (Reporting) CIK: 0001849673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37544 | Film No.: 251121788